D. E. Shaw & Co., Inc. Invitae Corp Put Options Transaction History

D. E. Shaw & Co., Inc.

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 16, 2022	SELL	$6.28 - $15.59 $1.14 Million - $2.84 Million	-182,000 Reduced 81.98%	40,000 $319,000
Q4 2021 Feb 14, 2022	BUY	$14.7 - $28.67 $1.03 Million - $2.01 Million	70,000 Added 46.05%	222,000 $3.39 Million
Q3 2021 Nov 15, 2021	BUY	$24.31 - $33.6 $106,964 - $147,840	4,400 Added 2.98%	152,000 $4.32 Million
Q2 2021 Aug 16, 2021	BUY	$26.09 - $40.4 $2.37 Million - $3.68 Million	91,000 Added 160.78%	147,600 $4.98 Million
Q1 2021 May 17, 2021	SELL	$33.06 - $56.93 $1.4 Million - $2.4 Million	-42,200 Reduced 42.71%	56,600 $2.16 Million
Q4 2020 Feb 16, 2021	BUY	$39.09 - $57.4 $2.74 Million - $4.02 Million	70,000 Added 243.06%	98,800 $4.13 Million
Q3 2020 Nov 16, 2020	SELL	$28.43 - $44.67 $34,116 - $53,604	-1,200 Reduced 4.0%	28,800 $1.25 Million
Q2 2019 Aug 14, 2019	BUY	$17.37 - $26.27 $521,100 - $788,100	30,000 New	30,000 $705,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.